The market continued its alternating pattern of gains and losses for the fourth straight session on Tuesday, August 5. After a sustainable upmove on...
The US Food and Drug Administration (USFDA) has issued a Warning Letter to Glenmark Pharmaceuticals for its Pithampur manufacturing facility, following an inspection conducted...